Medication Education for Dosing Safety

Study Overview
=================
Brief Summary
-----------------
Acetaminophen and ibuprofen are two of the most commonly used medication products among children <12 years old, and these medications are frequently prescribed for patients leaving the emergency department (ED), but previous studies have shown that parents often leave the ED unsure of how to safely dose these medications at home. This study will be a randomized controlled trial of a brief medication safety intervention, and examining parental knowledge and implementation of appropriate weight-based dosing.

Official Title
-----------------
Medication Education for Dosing Safety

Conditions
-----------------
Pain, Fever

Intervention / Treatment
-----------------
* Other: Additional teaching


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: parents of children between ages of 90 days to 11.9 years being discharged with a plan for use of liquid acetaminophen (any age) or ibuprofen (limited to those >6 months old). The clinical team will determine planned medication use. parental fluency in English or Spanish ability to be reached by telephone over the next 7 days planned discharge home. Exclusion Criteria: presence of a complex chronic condition in the child planned use of a non-standard weight-based medication dose. Families will also be excluded if the adult with the child is not a parent or legal guardian.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Health Services Research
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Usual care<br> | |
| Experimental: Additional teaching<br> | Other: Additional teaching<br>* A brief safety intervention, combining a pictorial handout, dosing demonstration with dispensed syringe, and teach-back for confirmation of understanding.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Participants Reporting Safe Dosing at 48-72 Hours | Number of participants reporting dosing within 20% of the weight-based dose for the child at 48-72 hours | 48-72 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of Participants Reporting Persistence of Safe Dosing at 5-7 Days | Number of participants reporting dosing within 20% of the weight-based dose for the child at 5-7 days | 5-7 days | 
| Number of Participants Reporting Contact With Other Providers at 48-72 Hours | Number of participants reporting visit to primary care or emergency department providers at 48-72 hours | 48-72 hours | 
| Number of Participants Reporting Contact With Other Providers at 5-7 Days | Number of participants reporting visit to primary care or emergency department providers at 5-7 days. | 5-7 days |